{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:33:19Z","timestamp":1792801999504,"version":"4.5.0"},"reference-count":108,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2019,2,6]],"date-time":"2019-02-06T00:00:00Z","timestamp":1549411200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The superfamily of tumor necrosis factor (TNF) receptors includes osteoprotegerin (OPG) and its ligands, which are receptor activators of nuclear factor kappa-B ligand (RANKL) and TNF-related apoptosis-inducing ligand (TRAIL). The OPG\/RANKL\/RANK system plays an active role in pathological angiogenesis and inflammation as well as cell survival. It has been demonstrated that there is crosstalk between endothelial cells and osteoblasts during osteogenesis, thus establishing a connection between angiogenesis and osteogenesis. This OPG\/RANKL\/RANK\/TRAIL system acts on specific cell surface receptors, which are then able to transmit their signals to other intracellular components and modify gene expression. Cytokine production and activation of their receptors induce mechanisms to recruit monocytes and neutrophils as well as endothelial cells. Data support the role of an increased OPG\/RANKL ratio as a possible marker of progression of endothelial dysfunction in metabolic disorders in relationship with inflammatory marker levels. We review the role of the OPG\/RANKL\/RANK triad in vascular function as well as molecular mechanisms related to the etiology of vascular diseases. The potential therapeutic strategies may be very promising in the future.<\/jats:p>","DOI":"10.3390\/ijms20030705","type":"journal-article","created":{"date-parts":[[2019,2,6]],"date-time":"2019-02-06T11:51:12Z","timestamp":1549453872000},"page":"705","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":139,"title":["The Role of Osteoprotegerin and Its Ligands in Vascular Function"],"prefix":"10.3390","volume":"20","author":[{"given":"Luc","family":"Rochette","sequence":"first","affiliation":[{"name":"Equipe d\u2019Accueil (EA 7460): Physiopathologie et Epid\u00e9miologie C\u00e9r\u00e9bro-Cardiovasculaires (PEC2), Universit\u00e9 de Bourgogne\u2013Franche Comt\u00e9, Facult\u00e9 des Sciences de Sant\u00e9, 7 Bd Jeanne d\u2019Arc, 21000 Dijon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Meloux","sequence":"additional","affiliation":[{"name":"Equipe d\u2019Accueil (EA 7460): Physiopathologie et Epid\u00e9miologie C\u00e9r\u00e9bro-Cardiovasculaires (PEC2), Universit\u00e9 de Bourgogne\u2013Franche Comt\u00e9, Facult\u00e9 des Sciences de Sant\u00e9, 7 Bd Jeanne d\u2019Arc, 21000 Dijon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eve","family":"Rigal","sequence":"additional","affiliation":[{"name":"Equipe d\u2019Accueil (EA 7460): Physiopathologie et Epid\u00e9miologie C\u00e9r\u00e9bro-Cardiovasculaires (PEC2), Universit\u00e9 de Bourgogne\u2013Franche Comt\u00e9, Facult\u00e9 des Sciences de Sant\u00e9, 7 Bd Jeanne d\u2019Arc, 21000 Dijon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5763-4579","authenticated-orcid":false,"given":"Marianne","family":"Zeller","sequence":"additional","affiliation":[{"name":"Equipe d\u2019Accueil (EA 7460): Physiopathologie et Epid\u00e9miologie C\u00e9r\u00e9bro-Cardiovasculaires (PEC2), Universit\u00e9 de Bourgogne\u2013Franche Comt\u00e9, Facult\u00e9 des Sciences de Sant\u00e9, 7 Bd Jeanne d\u2019Arc, 21000 Dijon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Cottin","sequence":"additional","affiliation":[{"name":"Equipe d\u2019Accueil (EA 7460): Physiopathologie et Epid\u00e9miologie C\u00e9r\u00e9bro-Cardiovasculaires (PEC2), Universit\u00e9 de Bourgogne\u2013Franche Comt\u00e9, Facult\u00e9 des Sciences de Sant\u00e9, 7 Bd Jeanne d\u2019Arc, 21000 Dijon, France"},{"name":"Service de Cardiologie\u2013CHU-Dijon, 21000 Dijon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Vergely","sequence":"additional","affiliation":[{"name":"Equipe d\u2019Accueil (EA 7460): Physiopathologie et Epid\u00e9miologie C\u00e9r\u00e9bro-Cardiovasculaires (PEC2), Universit\u00e9 de Bourgogne\u2013Franche Comt\u00e9, Facult\u00e9 des Sciences de Sant\u00e9, 7 Bd Jeanne d\u2019Arc, 21000 Dijon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,2,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3389\/fimmu.2014.00511","article-title":"Biology of the RANKL-RANK-OPG System in Immunity, Bone, and Beyond","volume":"5","author":"Walsh","year":"2014","journal-title":"Front. Immunol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.pharmthera.2017.08.015","article-title":"The role of osteoprotegerin in the crosstalk between vessels and bone: Its potential utility as a marker of cardiometabolic diseases","volume":"182","author":"Rochette","year":"2018","journal-title":"Pharm. Ther."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"6059","DOI":"10.3892\/mmr.2017.7376","article-title":"Cardiovascular risk assessment in osteoporotic patients using osteoprotegerin as a reliable predictive biochemical marker","volume":"16","author":"Barbu","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.vph.2016.02.003","article-title":"Vascular calcification in type-2 diabetes and cardiovascular disease: Integrative roles for OPG, RANKL and TRAIL","volume":"82","author":"Harper","year":"2016","journal-title":"Vasc. Pharm."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"167","DOI":"10.5312\/wjo.v3.i11.167","article-title":"Molecular mechanisms of triggering, amplifying and targeting RANK signaling in osteoclasts","volume":"3","author":"Kuroda","year":"2012","journal-title":"World J. Orthop."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00011-016-0934-1","article-title":"Distinct roles of TNF-related apoptosis-inducing ligand (TRAIL) in viral and bacterial infections: From pathogenesis to pathogen clearance","volume":"65","author":"Gyurkovska","year":"2016","journal-title":"Inflamm. Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.atherosclerosis.2016.02.002","article-title":"The beneficial pleiotropic effects of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) within the vasculature: A review of the evidence","volume":"247","author":"Forde","year":"2016","journal-title":"Atherosclerosis"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1002\/jcb.25223","article-title":"Tumor Necrosis Factor Related Apoptosis Inducing Ligand (Trail) in endothelial response to biomechanical and biochemical stresses in arteries","volume":"116","author":"Centurione","year":"2015","journal-title":"J. Cell. Biochem."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"5022","DOI":"10.1074\/jbc.M115.683946","article-title":"Binding Studies of TNF Receptor Superfamily (TNFRSF) Receptors on Intact Cells","volume":"291","author":"Lang","year":"2016","journal-title":"J. Biol. Chem."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"316","DOI":"10.14348\/molcells.2016.2286","article-title":"Design of a RANK-Mimetic Peptide Inhibitor of Osteoclastogenesis with Enhanced RANKL-Binding Affinity","volume":"39","author":"Hur","year":"2016","journal-title":"Mol. Cells"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"9141","DOI":"10.1021\/acs.jpcb.7b06687","article-title":"Unraveling Binding Interactions between Human RANKL and Its Decoy Receptor Osteoprotegerin","volume":"121","author":"Munasinghe","year":"2017","journal-title":"J. Phys. Chem. B"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","article-title":"Osteoprotegerin: A novel secreted protein involved in the regulation of bone density","volume":"89","author":"Simonet","year":"1997","journal-title":"Cell"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1002\/jcb.21129","article-title":"Osteoprotegerin expression in dendritic cells increases with maturation and is NF-kappaB-dependent","volume":"100","author":"Schoppet","year":"2007","journal-title":"J. Cell. Biochem."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1038\/cdd.2016.89","article-title":"Thrombospondin 1 protects pancreatic beta-cells from lipotoxicity via the PERK-NRF2 pathway","volume":"23","author":"Cunha","year":"2016","journal-title":"Cell Death Differ."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"643406","DOI":"10.1155\/2014\/643406","article-title":"TLR2 elicits IL-17-mediated RANKL expression, IL-17, and OPG production in neutrophils from arthritic mice","volume":"2014","author":"Milanova","year":"2014","journal-title":"Mediat. Inflamm."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Lee, G.L., Yeh, C.C., Wu, J.Y., Lin, H.C., Wang, Y.F., Kuo, Y.Y., Hsieh, Y.T., Hsu, Y.J., and Kuo, C.C. (2019). TLR2 Promotes Vascular Smooth Muscle Cell Chondrogenic Differentiation and Consequent Calcification Via the Concerted Actions of Osteoprotegerin Suppression and IL-6-Mediated RANKL Induction. Arter. Thromb. Vasc. Biol.","DOI":"10.1016\/j.atherosclerosis.2019.06.078"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1684\/ecn.2017.0393","article-title":"Predictive ability of circulating osteoprotegerin as a novel biomarker for early detection of acute kidney injury induced by sepsis","volume":"28","author":"Schaalan","year":"2017","journal-title":"Eur. Cytokine Netw."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1002\/art.37997","article-title":"Osteoprotegerin causes apoptosis of endothelial progenitor cells by induction of oxidative stress","volume":"65","author":"Kim","year":"2013","journal-title":"Arthritis Rheum."},{"key":"ref_19","first-page":"195","article-title":"Adipose-derived stem cell-released osteoprotegerin protects cardiomyocytes from reactive oxygen species-induced cell death","volume":"8","author":"Lee","year":"2017","journal-title":"Stem Cell Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.3390\/ijms16023885","article-title":"A variant in the osteoprotegerin gene is associated with coronary atherosclerosis in patients with rheumatoid arthritis: Results from a candidate gene study","volume":"16","author":"Chung","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1016\/j.bbadis.2013.09.004","article-title":"Cardiac matrix: A clue for future therapy","volume":"1832","author":"Mishra","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1152\/physrev.00017.2002","article-title":"Cardiac endothelial-myocardial signaling: Its role in cardiac growth, contractile performance, and rhythmicity","volume":"83","author":"Brutsaert","year":"2003","journal-title":"Physiol. Rev."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1161\/CIRCRESAHA.116.302855","article-title":"Endothelial cell metabolism in normal and diseased vasculature","volume":"116","author":"Eelen","year":"2015","journal-title":"Circ. Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"C205","DOI":"10.1152\/ajpcell.1997.273.1.C205","article-title":"Energy turnover of vascular endothelial cells","volume":"273","author":"Culic","year":"1997","journal-title":"Am. J. Physiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/nature14362","article-title":"Fatty acid carbon is essential for dNTP synthesis in endothelial cells","volume":"520","author":"Schoors","year":"2015","journal-title":"Nature"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1161\/CIRCRESAHA.113.302095","article-title":"Cardiac metabolism and its interactions with contraction, growth, and survival of cardiomyocytes","volume":"113","author":"Kolwicz","year":"2013","journal-title":"Circ. Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1161\/ATVBAHA.113.301588","article-title":"Capillary endothelial fatty acid binding proteins 4 and 5 play a critical role in fatty acid uptake in heart and skeletal muscle","volume":"33","author":"Iso","year":"2013","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nature08945","article-title":"Vascular endothelial growth factor B controls endothelial fatty acid uptake","volume":"464","author":"Hagberg","year":"2010","journal-title":"Nature"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/cvr\/cvn301","article-title":"Energy metabolism in heart failure and remodelling","volume":"81","author":"Ingwall","year":"2009","journal-title":"Cardiovasc. Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1161\/CIRCULATIONAHA.107.702795","article-title":"Metabolic mechanisms in heart failure","volume":"116","author":"Ashrafian","year":"2007","journal-title":"Circulation"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1359\/JBMR.051021","article-title":"Human osteoblast precursors produce extracellular adenosine, which modulates their secretion of IL-6 and osteoprotegerin","volume":"21","author":"Evans","year":"2006","journal-title":"J. Bone Miner. Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"6509754","DOI":"10.1155\/2017\/6509754","article-title":"Myocardial Perfusion in Rheumatoid Arthritis Patients: Associations with Traditional Risk Factors and Novel Biomarkers","volume":"2017","author":"Bernardes","year":"2017","journal-title":"Biomed. Res. Int."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1007\/s10067-016-3202-4","article-title":"The A3 adenosine receptor (A3AR): Therapeutic target and predictive biological marker in rheumatoid arthritis","volume":"35","author":"Fishman","year":"2016","journal-title":"Clin. Rheumatol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.bbrc.2004.01.024","article-title":"NF-kappaB-dependent induction of osteoprotegerin by Porphyromonas gingivalis in endothelial cells","volume":"315","author":"Hirose","year":"2004","journal-title":"BioChem. Biophys. Res. Commun"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.mvr.2008.06.004","article-title":"Role of alphav integrin in osteoprotegerin-induced endothelial cell migration and proliferation","volume":"76","author":"Isogai","year":"2008","journal-title":"Microvasc. Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s10456-013-9337-x","article-title":"Mechanistic study of the proangiogenic effect of osteoprotegerin","volume":"16","author":"Poirier","year":"2013","journal-title":"Angiogenesis"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2174\/1573402111666150213165054","article-title":"Heparan sulphate as a regulator of leukocyte recruitment in inflammation","volume":"16","author":"Kumar","year":"2015","journal-title":"Curr. Protein Pept. Sci."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1161\/ATVBAHA.110.216184","article-title":"Mitral valve endothelial cells with osteogenic differentiation potential","volume":"31","author":"Aikawa","year":"2011","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.yjmcc.2016.06.061","article-title":"Mitral valve endothelial cells secrete osteoprotegerin during endothelial mesenchymal transition","volume":"98","author":"Songia","year":"2016","journal-title":"J. Mol. Cell Cardiol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.atherosclerosis.2011.08.027","article-title":"High-density lipoproteins (HDL) are present in stenotic aortic valves and may interfere with the mechanisms of valvular calcification","volume":"219","author":"Lommi","year":"2011","journal-title":"Atherosclerosis"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.pharmthera.2013.07.004","article-title":"Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: Possible therapeutic targets?","volume":"140","author":"Rochette","year":"2013","journal-title":"Pharm. Ther."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1016\/j.bbagen.2014.05.017","article-title":"Diabetes, oxidative stress and therapeutic strategies","volume":"1840","author":"Rochette","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0014-5793(02)02872-7","article-title":"PDGF induces osteoprotegerin expression in vascular smooth muscle cells by multiple signal pathways","volume":"521","author":"Zhang","year":"2002","journal-title":"FEBS Lett."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Kleemann, R., Bureeva, S., Perlina, A., Kaput, J., Verschuren, L., Wielinga, P.Y., Hurt-Camejo, E., Nikolsky, Y., van Ommen, B., and Kooistra, T. (2011). A systems biology strategy for predicting similarities and differences of drug effects: Evidence for drug-specific modulation of inflammation in atherosclerosis. BMC Syst. Biol., 5.","DOI":"10.1186\/1752-0509-5-125"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1083\/jcb.200410073","article-title":"The subendothelial extracellular matrix modulates NF-kappaB activation by flow: A potential role in atherosclerosis","volume":"169","author":"Orr","year":"2005","journal-title":"J. Cell Biol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1089\/ars.2015.6493","article-title":"Endothelial Mechanosignaling: Does One Sensor Fit All?","volume":"25","author":"Givens","year":"2016","journal-title":"Antioxid. Redox Signal."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.bone.2017.04.003","article-title":"Shear stress inhibits IL-17A-mediated induction of osteoclastogenesis via osteocyte pathways","volume":"101","author":"Liao","year":"2017","journal-title":"Bone"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"209","DOI":"10.4331\/wjbc.v6.i3.209","article-title":"Inflammation, oxidative stress and renin angiotensin system in atherosclerosis","volume":"6","author":"Husain","year":"2015","journal-title":"World J. Biol. Chem."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"20959","DOI":"10.1074\/jbc.C000290200","article-title":"Osteoprotegerin is an alpha vbeta 3-induced, NF-kappa B-dependent survival factor for endothelial cells","volume":"275","author":"Malyankar","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.atherosclerosis.2014.06.011","article-title":"Angiotensin receptor 1 blockade reduces secretion of inflammation associated cytokines from cultured human carotid atheroma and vascular cells in association with reduced extracellular signal regulated kinase expression and activation","volume":"236","author":"Clancy","year":"2014","journal-title":"Atherosclerosis"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ymgme.2015.02.006","article-title":"Losartan increases bone mass and accelerates chondrocyte hypertrophy in developing skeleton","volume":"115","author":"Chen","year":"2015","journal-title":"Mol. Genet. Metab."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"39548","DOI":"10.1074\/jbc.M300539200","article-title":"Vascular endothelial growth factor up-regulates expression of receptor activator of NF-kappa B (RANK) in endothelial cells. Concomitant increase of angiogenic responses to RANK ligand","volume":"278","author":"Min","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1146\/annurev-physiol-021115-105134","article-title":"The Link Between Angiogenesis and Endothelial Metabolism","volume":"79","author":"Potente","year":"2017","journal-title":"Annu. Rev. Physiol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1600-0609.2010.01446.x","article-title":"Osteoprotegerin induces cytoskeletal reorganization and activates FAK, Src, and ERK signaling in endothelial cells","volume":"85","author":"Isogai","year":"2010","journal-title":"Eur. J. Haematol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nature13145","article-title":"Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone","volume":"507","author":"Kusumbe","year":"2014","journal-title":"Nature"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Veeriah, V., Paone, R., Chatterjee, S., Teti, A., and Capulli, M. (2018). Osteoblasts Regulate Angiogenesis in Response to Mechanical Unloading. Calcif. Tissue Int.","DOI":"10.1007\/s00223-018-0496-z"},{"key":"ref_57","first-page":"12","article-title":"Exosomes secreted by endothelial progenitor cells accelerate bone regeneration during distraction osteogenesis by stimulating angiogenesis","volume":"10","author":"Jia","year":"2019","journal-title":"Stem Cell Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1161\/01.ATV.0000236428.91125.e6","article-title":"Osteoprotegerin inactivation accelerates advanced atherosclerotic lesion progression and calcification in older ApoE-\/- mice","volume":"26","author":"Bennett","year":"2006","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1161\/CIRCULATIONAHA.104.464727","article-title":"Association of osteoprotegerin with human abdominal aortic aneurysm progression","volume":"111","author":"Moran","year":"2005","journal-title":"Circulation"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1160\/TH11-05-0324","article-title":"Receptor activator of NF- kappaB ligand (RANKL) increases the release of neutrophil products associated with coronary vulnerability","volume":"107","author":"Quercioli","year":"2012","journal-title":"Thromb. Haemost."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1189\/jlb.0310149","article-title":"The regulatory role of nitric oxide in proinflammatory cytokine expression during the induction and resolution of inflammation","volume":"88","author":"Kobayashi","year":"2010","journal-title":"J. Leukoc. Biol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1182\/blood-2007-01-068395","article-title":"Osteoprotegerin increases leukocyte adhesion to endothelial cells both in vitro and in vivo","volume":"110","author":"Zauli","year":"2007","journal-title":"Blood"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.cardiores.2007.07.017","article-title":"Osteoprotegerin upregulates endothelial cell adhesion molecule response to tumor necrosis factor-alpha associated with induction of angiopoietin-2","volume":"76","author":"Mangan","year":"2007","journal-title":"Cardiovasc. Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3389\/fphar.2017.00363","article-title":"IL-1beta Inhibition in Cardiovascular Complications Associated to Diabetes Mellitus","volume":"8","author":"Peiro","year":"2017","journal-title":"Front. Pharmacol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2217\/imt-2017-0075","article-title":"A review of sarilumab for the treatment of rheumatoid arthritis","volume":"10","author":"Lee","year":"2018","journal-title":"Immunotherapy"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12943-017-0606-y","article-title":"Osteoprotegerin mediates tumor-promoting effects of Interleukin-1beta in breast cancer cells","volume":"16","author":"Chung","year":"2017","journal-title":"Mol. Cancer"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.bbrc.2013.09.072","article-title":"Oxidized low density lipoprotein increases RANKL level in human vascular cells. Involvement of oxidative stress","volume":"440","author":"Maziere","year":"2013","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.atherosclerosis.2006.08.002","article-title":"The relationship between oxidized LDL and other cardiovascular risk factors and subclinical CVD in different ethnic groups: The Multi-Ethnic Study of Atherosclerosis (MESA)","volume":"194","author":"Holvoet","year":"2007","journal-title":"Atherosclerosis"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"8191","DOI":"10.1073\/pnas.1400544111","article-title":"OPG\/RANKL\/RANK axis is a critical inflammatory signaling system in ischemic brain in mice","volume":"111","author":"Shimamura","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1161\/CIRCRESAHA.116.305348","article-title":"Molecular basis of cardioprotection: Signal transduction in ischemic pre-, post-, and remote conditioning","volume":"116","author":"Heusch","year":"2015","journal-title":"Circ. Res."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"H1029","DOI":"10.1152\/ajpheart.00527.2015","article-title":"Fibroblast growth factors in cardiovascular disease: The emerging role of FGF21","volume":"309","author":"Domouzoglou","year":"2015","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1111\/jphp.12826","article-title":"Fibroblast growth factor 21 attenuates calcification of vascular smooth muscle cells in vitro","volume":"69","author":"Cao","year":"2017","journal-title":"J. Pharm. Pharm."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1126\/science.1251141","article-title":"Vascular and neurogenic rejuvenation of the aging mouse brain by young systemic factors","volume":"344","author":"Katsimpardi","year":"2014","journal-title":"Science"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.pharmthera.2015.10.006","article-title":"Growth and differentiation factor 11 (GDF11): Functions in the regulation of erythropoiesis and cardiac regeneration","volume":"156","author":"Rochette","year":"2015","journal-title":"Pharm. Ther."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"12794","DOI":"10.1038\/ncomms12794","article-title":"GDF11 decreases bone mass by stimulating osteoclastogenesis and inhibiting osteoblast differentiation","volume":"7","author":"Liu","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s00395-017-0639-9","article-title":"Exogenous GDF11 induces cardiac and skeletal muscle dysfunction and wasting","volume":"112","author":"Zimmers","year":"2017","journal-title":"Basic Res. Cardiol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/cvr\/cvp315","article-title":"The ubiquitin-proteasome pathway and endothelial (dys)function","volume":"85","author":"Stangl","year":"2010","journal-title":"Cardiovasc. Res."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.exger.2017.06.007","article-title":"Vascular ageing: Underlying mechanisms and clinical implications","volume":"109","author":"Laina","year":"2018","journal-title":"Exp. Gerontol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1161\/CIRCULATIONAHA.106.637827","article-title":"Activation of the cardiac proteasome during pressure overload promotes ventricular hypertrophy","volume":"114","author":"Depre","year":"2006","journal-title":"Circulation"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1161\/01.CIR.0000165119.62099.14","article-title":"Dysregulated osteoprotegerin\/RANK ligand\/RANK axis in clinical and experimental heart failure","volume":"111","author":"Ueland","year":"2005","journal-title":"Circulation"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s10654-016-0172-4","article-title":"Plasma osteoprotegerin, its correlates, and risk of heart failure: A prospective cohort study","volume":"32","author":"Biemann","year":"2017","journal-title":"Eur. J. Epidemiol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.atherosclerosis.2011.09.026","article-title":"Smoking and FOS expression from blood leukocyte transcripts in patients with coronary artery disease","volume":"219","author":"Saliques","year":"2011","journal-title":"Atherosclerosis"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1158\/1078-0432.CCR-10-2507","article-title":"Molecular pathways: Osteoclast-dependent and osteoclast-independent roles of the RANKL\/RANK\/OPG pathway in tumorigenesis and metastasis","volume":"18","author":"Dougall","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"841","DOI":"10.3892\/or.2015.4473","article-title":"Identification of novel therapeutic targets in the secretome of ionizing radiationinduced senescent tumor cells","volume":"35","author":"Hwang","year":"2016","journal-title":"Oncol. Rep."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1159\/000431091","article-title":"Immunology of Osteoporosis: A Mini-Review","volume":"62","author":"Pietschmann","year":"2016","journal-title":"Gerontology"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3389\/fcvm.2018.00183","article-title":"The Interplay of SIRT1 and Wnt Signaling in Vascular Calcification","volume":"5","author":"Wilkinson","year":"2018","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Davaine, J.M., Quillard, T., Brion, R., Laperine, O., Guyomarch, B., Merlini, T., Chatelais, M., Guilbaud, F., Brennan, M.A., and Charrier, C. (2014). Osteoprotegerin, pericytes and bone-like vascular calcification are associated with carotid plaque stability. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0107642"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"480","DOI":"10.3389\/fimmu.2016.00480","article-title":"Immune Regulation by Pericytes: Modulating Innate and Adaptive Immunity","volume":"7","author":"Navarro","year":"2016","journal-title":"Front. Immunol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"L556","DOI":"10.1152\/ajplung.00349.2016","article-title":"Lung pericyte-like cells are functional interstitial immune sentinel cells","volume":"312","author":"Hung","year":"2017","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1111\/j.1538-7836.2011.04207.x","article-title":"Osteoprotegerin, a new actor in vasculogenesis, stimulates endothelial colony-forming cells properties","volume":"9","author":"Heymann","year":"2011","journal-title":"J. Thromb. Haemost. JTH"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1167\/iovs.16-20993","article-title":"Osteoprotegerin Is a New Regulator of Inflammation and Angiogenesis in Proliferative Diabetic Retinopathy","volume":"58","author":"Struyf","year":"2017","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_92","first-page":"65","article-title":"Skeletal and cardiac muscle pericytes: Functions and therapeutic potential","volume":"171","author":"Murray","year":"2017","journal-title":"Pharm."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/stem.1285","article-title":"Human pericytes for ischemic heart repair","volume":"31","author":"Chen","year":"2013","journal-title":"Stem Cells"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00223-013-9712-z","article-title":"Vascular calcification: An update on mechanisms and challenges in treatment","volume":"93","author":"Wu","year":"2013","journal-title":"Calcif. Tissue Int."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"41155","DOI":"10.1074\/jbc.M506366200","article-title":"Functional dissection of osteoprotegerin and its interaction with receptor activator of NF-kappaB ligand","volume":"280","author":"Schneeweis","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1161\/CIRCRESAHA.108.189001","article-title":"RANKL increases vascular smooth muscle cell calcification through a RANK-BMP4-dependent pathway","volume":"104","author":"Panizo","year":"2009","journal-title":"Circ. Res."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.atherosclerosis.2014.12.004","article-title":"Low concentrations of phospholipids and plasma HDL cholesterol subclasses in asymptomatic subjects with high coronary calcium scores","volume":"238","author":"Fragoso","year":"2015","journal-title":"Atherosclerosis"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1161\/01.RES.0000026421.61398.F2","article-title":"Induction of bone-type alkaline phosphatase in human vascular smooth muscle cells: Roles of tumor necrosis factor-alpha and oncostatin M derived from macrophages","volume":"91","author":"Shioi","year":"2002","journal-title":"Circ. Res."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1536\/ihj.15-150","article-title":"Osteoprotegerin is Associated with Endothelial Function and Predicts Early Carotid Atherosclerosis in Patients With Coronary Artery Disease","volume":"56","author":"Morisawa","year":"2015","journal-title":"Int. Heart J."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.atherosclerosis.2017.03.030","article-title":"Association between serum alkaline phosphatase and coronary artery calcification in a sample of primary cardiovascular prevention patients","volume":"260","author":"Panh","year":"2017","journal-title":"Atherosclerosis"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.amjcard.2009.02.053","article-title":"Relation of multiple inflammatory biomarkers to incident atrial fibrillation","volume":"104","author":"Schnabel","year":"2009","journal-title":"Am. J. Cardiol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1001\/jamacardio.2017.0064","article-title":"Association Between Vascular Cell Adhesion Molecule 1 and Atrial Fibrillation","volume":"2","author":"Willeit","year":"2017","journal-title":"Jama Cardiol"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1161\/CIRCULATIONAHA.107.743161","article-title":"Vascular calcification: Pathobiology of a multifaceted disease","volume":"117","author":"Demer","year":"2008","journal-title":"Circulation"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ctrv.2017.10.010","article-title":"The anti-tumor effect of RANKL inhibition in malignant solid tumors\u2014A systematic review","volume":"62","author":"Kroep","year":"2018","journal-title":"Cancer Treat. Rev."},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Murakami, K., Kobayashi, Y., Uehara, S., Suzuki, T., Koide, M., Yamashita, T., Nakamura, M., Takahashi, N., Kato, H., and Udagawa, N. (2017). A Jak1\/2 inhibitor, baricitinib, inhibits osteoclastogenesis by suppressing RANKL expression in osteoblasts in vitro. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0181126"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1056\/NEJMoa0912923","article-title":"NT5E mutations and arterial calcifications","volume":"364","author":"Ziegler","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1080\/14728222.2019.1559829","article-title":"CD73 as a potential opportunity for cancer immunotherapy","volume":"23","author":"Ghalamfarsa","year":"2019","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1021\/acsmedchemlett.7b00255","article-title":"Inhibitors of CD73 May Provide a Treatment for Cancer and Autoimmune Diseases","volume":"8","year":"2017","journal-title":"ACS Med. Chem. Lett."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/20\/3\/705\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:31:24Z","timestamp":1760185884000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/20\/3\/705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,6]]},"references-count":108,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,2]]}},"alternative-id":["ijms20030705"],"URL":"https:\/\/doi.org\/10.3390\/ijms20030705","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,6]]}}}